These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 8577398)
1. Amyloid beta-peptide in cerebrospinal fluid in individuals with the Swedish Alzheimer amyloid precursor protein mutation. Lannfelt L; Basun H; Vigo-Pelfrey C; Wahlund LO; Winblad B; Lieberburg I; Schenk D Neurosci Lett; 1995 Oct; 199(3):203-6. PubMed ID: 8577398 [TBL] [Abstract][Full Text] [Related]
2. Decreased alpha-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease. Lannfelt L; Basun H; Wahlund LO; Rowe BA; Wagner SL Nat Med; 1995 Aug; 1(8):829-32. PubMed ID: 7585189 [TBL] [Abstract][Full Text] [Related]
3. The significance of the Swedish APP670/671 mutation for the development of Alzheimer's disease amyloidosis. Johnston J; O'Neill C; Lannfelt L; Winblad B; Cowburn RF Neurochem Int; 1994 Jul; 25(1):73-80. PubMed ID: 7950974 [TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity. Hock C; Golombowski S; Müller-Spahn F; Naser W; Beyreuther K; Mönning U; Schenk D; Vigo-Pelfrey C; Bush AM; Moir R; Tanzi RE; Growdon JH; Nitsch RM Eur Neurol; 1998; 39(2):111-8. PubMed ID: 9520072 [TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid levels of alpha-secretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation. Almkvist O; Basun H; Wagner SL; Rowe BA; Wahlund LO; Lannfelt L Arch Neurol; 1997 May; 54(5):641-4. PubMed ID: 9152122 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Expression of Amyloid Precursor Protein and the Ratio of Secreted Amyloid Beta 42 to Amyloid Beta 40 in SH-SY5Y Cells Stably Transfected with Wild-Type, Single-Mutant and Double-Mutant Forms of the APP Gene for the Study of Alzheimer's Disease Pathology. Pahrudin Arrozi A; Shukri SNS; Wan Ngah WZ; Mohd Yusof YA; Ahmad Damanhuri MH; Makpol S Appl Biochem Biotechnol; 2017 Nov; 183(3):853-866. PubMed ID: 28417423 [TBL] [Abstract][Full Text] [Related]
7. Increased beta-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation. Johnston JA; Cowburn RF; Norgren S; Wiehager B; Venizelos N; Winblad B; Vigo-Pelfrey C; Schenk D; Lannfelt L; O'Neill C FEBS Lett; 1994 Nov; 354(3):274-8. PubMed ID: 7957938 [TBL] [Abstract][Full Text] [Related]
8. Low cerebrospinal-fluid concentrations of soluble amyloid beta-protein precursor in hereditary Alzheimer's disease. Farlow M; Ghetti B; Benson MD; Farrow JS; van Nostrand WE; Wagner SL Lancet; 1992 Aug; 340(8817):453-4. PubMed ID: 1354785 [TBL] [Abstract][Full Text] [Related]
9. Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Mann DM; Iwatsubo T; Ihara Y; Cairns NJ; Lantos PL; Bogdanovic N; Lannfelt L; Winblad B; Maat-Schieman ML; Rossor MN Am J Pathol; 1996 Apr; 148(4):1257-66. PubMed ID: 8644866 [TBL] [Abstract][Full Text] [Related]
10. [Alzheimer disease: cellular and molecular aspects]. Octave JN Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248 [TBL] [Abstract][Full Text] [Related]
11. Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients. Van Nostrand WE; Wagner SL; Shankle WR; Farrow JS; Dick M; Rozemuller JM; Kuiper MA; Wolters EC; Zimmerman J; Cotman CW Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2551-5. PubMed ID: 1557359 [TBL] [Abstract][Full Text] [Related]
12. Frameshifted beta-amyloid precursor protein (APP+1) is a secretory protein, and the level of APP+1 in cerebrospinal fluid is linked to Alzheimer pathology. Hol EM; van Dijk R; Gerez L; Sluijs JA; Hobo B; Tonk MT; de Haan A; Kamphorst W; Fischer DF; Benne R; van Leeuwen FW J Biol Chem; 2003 Oct; 278(41):39637-43. PubMed ID: 12900421 [TBL] [Abstract][Full Text] [Related]
13. Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family. Lannfelt L; Bogdanovic N; Appelgren H; Axelman K; Lilius L; Hansson G; Schenk D; Hardy J; Winblad B Neurosci Lett; 1994 Feb; 168(1-2):254-6. PubMed ID: 8028788 [TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis-Dutch type share a decrease in cerebrospinal fluid levels of amyloid beta-protein precursor. Van Nostrand WE; Wagner SL; Haan J; Bakker E; Roos RA Ann Neurol; 1992 Aug; 32(2):215-8. PubMed ID: 1510361 [TBL] [Abstract][Full Text] [Related]
15. Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid. Portelius E; Brinkmalm G; Tran A; Andreasson U; Zetterberg H; Westman-Brinkmalm A; Blennow K; Ohrfelt A Exp Neurol; 2010 Jun; 223(2):351-8. PubMed ID: 19559702 [TBL] [Abstract][Full Text] [Related]
16. Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease. Thordardottir S; Ståhlbom AK; Ferreira D; Almkvist O; Westman E; Zetterberg H; Eriksdotter M; Blennow K; Graff C J Alzheimers Dis; 2015; 43(4):1393-402. PubMed ID: 25182737 [TBL] [Abstract][Full Text] [Related]
17. Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease. Basun H; Bogdanovic N; Ingelsson M; Almkvist O; Näslund J; Axelman K; Bird TD; Nochlin D; Schellenberg GD; Wahlund LO; Lannfelt L Arch Neurol; 2008 Apr; 65(4):499-505. PubMed ID: 18413473 [TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease families with amyloid precursor protein mutations. Rossor MN; Newman S; Frackowiak RS; Lantos P; Kennedy AM Ann N Y Acad Sci; 1993 Sep; 695():198-202. PubMed ID: 8239283 [TBL] [Abstract][Full Text] [Related]
19. Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation. Marutle A; Warpman U; Bogdanovic N; Lannfelt L; Nordberg A J Neurochem; 1999 Mar; 72(3):1161-9. PubMed ID: 10037489 [TBL] [Abstract][Full Text] [Related]